|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
|
US7374768B1
(en)
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
|
US6309647B1
(en)
*
|
1999-07-15 |
2001-10-30 |
Aventis Pasteur |
Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
|
|
ATE181108T1
(de)
|
1991-08-26 |
1999-06-15 |
Immuno Ag |
Direkt molekuläre klonierung eines modifizierten genoms eines chordopocken-virus
|
|
AU694519B2
(en)
*
|
1994-04-29 |
1998-07-23 |
Immuno Aktiengesellschaft |
Recombinant poxviruses with foreign polynucleotides in essential regions
|
|
FR2750865B1
(fr)
*
|
1996-06-27 |
1998-12-04 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
|
|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
US6368603B1
(en)
*
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
FR2775601B1
(fr)
*
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
|
US8017590B1
(en)
*
|
1999-10-22 |
2011-09-13 |
Sanofi Pasteur Limited |
Method of inducing and/or enhancing an immune response to tumor antigens
|
|
MXPA02006149A
(es)
*
|
1999-12-21 |
2003-01-28 |
Merial Sas |
Composiciones y vacunas las cuales contienen antigenos de cryptosporidium parvum y de otro patogeno enterico.
|
|
US20030027246A1
(en)
*
|
2000-03-31 |
2003-02-06 |
Artur Pedyczak |
Immunogenic peptides derived from prostate-specific membrane antigen (PSMA) and uses thereof
|
|
EP1282702B1
(en)
|
2000-05-10 |
2006-11-29 |
Sanofi Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
|
CZ295808B6
(cs)
|
2000-11-23 |
2005-11-16 |
Bavarian Nordic A/S |
Modifikovaný virus vakcinie typu Ankara
|
|
US7628980B2
(en)
*
|
2000-11-23 |
2009-12-08 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
US7097842B2
(en)
*
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US20070269456A1
(en)
*
|
2001-11-05 |
2007-11-22 |
Lasher Alfred W |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
US20030228327A1
(en)
*
|
2001-11-05 |
2003-12-11 |
Lasher Alfred W. |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
DE60314823T3
(de)
*
|
2002-04-19 |
2017-11-16 |
Bavarian Nordic A/S |
Modifizierte variante des vaccinia ankara virus als impfstoff für neugeborene
|
|
JP2006511194A
(ja)
|
2002-05-02 |
2006-04-06 |
デイビッド ラブジョイ |
テネウリンｃ末端関連ペプチド（ｔｃａｐ）並びにこれらに関連する方法および使用
|
|
BRPI0313559B8
(pt)
*
|
2002-09-05 |
2021-05-25 |
Bavarian Nordic As |
método para o cultivo de células primárias e para a amplificação de vírus sob condições isentas de soro
|
|
WO2004056977A1
(en)
*
|
2002-12-13 |
2004-07-08 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
|
JP2006514549A
(ja)
*
|
2002-12-16 |
2006-05-11 |
アメリカ合衆国 |
Ｉｌ−１５を発現する組換えワクチンウイルスおよびその使用方法
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
US20060240039A1
(en)
*
|
2003-06-13 |
2006-10-26 |
Isis Innovation Limited |
Vaccines
|
|
JP5576010B2
(ja)
|
2003-08-04 |
2014-08-20 |
ザ・ホスピタル・フォー・シック・チルドレン |
ラフォラ病遺伝子
|
|
ES2417019T3
(es)
|
2003-11-13 |
2013-08-05 |
University Of Georgia Research Foundation, Inc. |
Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
|
|
CA2580305A1
(en)
*
|
2004-06-02 |
2005-12-15 |
The Governors Of The University Of Alberta |
Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
|
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
ES2343270T3
(es)
|
2005-04-25 |
2010-07-27 |
Merial Ltd. |
Vacunas contra el virus nipah.
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
CA2629522A1
(en)
|
2005-11-14 |
2007-05-18 |
Merial Limited |
Gene therapy for renal failure
|
|
US7455844B2
(en)
|
2006-03-29 |
2008-11-25 |
Merial Limited |
Vaccine against streptococci
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
KR20150038558A
(ko)
|
2006-11-30 |
2015-04-08 |
탭이뮨, 인크. |
분자 아주반트로서 ｔａｐ―１ 및/또는 ｔａｐ―２를 포함하는 폭스비리대 치료
|
|
AU2007352618B2
(en)
|
2007-05-02 |
2013-07-18 |
Boehringer Ingelheim Animal Health USA Inc. |
DNA plasmids having improved expression and stability
|
|
MX348137B
(es)
|
2008-05-08 |
2017-05-29 |
Merial Ltd |
Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena.
|
|
WO2009155711A1
(en)
|
2008-06-27 |
2009-12-30 |
University Of Guelph |
Analysis of lactobacillus acidophilus la-5 signal interference molecules
|
|
PT2358742T
(pt)
|
2008-10-24 |
2018-06-04 |
Univ California |
Vacina contra vírus da peste equina africana
|
|
KR20200044990A
(ko)
|
2011-03-21 |
2020-04-29 |
알티뮨 인크. |
급속 및 지속적 면역학적제제-치료제
|
|
WO2012145577A1
(en)
|
2011-04-20 |
2012-10-26 |
Merial Limited |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
CA2837375C
(en)
|
2011-06-01 |
2019-07-16 |
Merial Limited |
Needle-free administration of prrsv vaccines
|
|
EP2734230B1
(en)
|
2011-07-20 |
2018-11-21 |
Merial Limited |
Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
|
|
DK2741740T3
(en)
|
2011-08-12 |
2017-06-06 |
Merial Inc |
VACUUM-SUPPORTED CONSERVATION OF BIOLOGICAL PRODUCTS, IN PARTICULAR OF VACCINES
|
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
|
WO2013123242A1
(en)
|
2012-02-14 |
2013-08-22 |
Merial Limited |
Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
|
|
WO2013142371A1
(en)
|
2012-03-20 |
2013-09-26 |
Merial Limited |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
|
CA2868575C
(en)
|
2012-03-27 |
2022-11-01 |
The University Of Western Ontario |
Sh2 domain variants
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
US9975944B2
(en)
|
2013-03-12 |
2018-05-22 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Synthetic peptides for the treatment of autoimmune diseases
|
|
US10010499B2
(en)
|
2014-11-03 |
2018-07-03 |
Merial Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
EP3042666A1
(en)
|
2015-01-06 |
2016-07-13 |
Rheinisch-Westfälische Technische Hochschule Aachen |
ITIH5 fragments for the treatment of cancer
|
|
ES2903443T3
(es)
|
2015-04-28 |
2022-04-01 |
Avivagen Inc |
Carotenoides oxidados y componentes de los mismos para prevenir la enteritis necrótica
|
|
US20210299245A1
(en)
*
|
2020-03-31 |
2021-09-30 |
Sementis Limited |
Attenuated poxvirus vector based vaccine for protection against covid-19
|
|
CN116656730B
(zh)
*
|
2023-05-25 |
2024-03-19 |
军事科学院军事医学研究院军事兽医研究所 |
一种表达狂犬病病毒g、m蛋白的重组金丝雀痘病毒及其构建方法
|
